LAMIVUDINE AND ZIDOVUDINE

Product NDC

57297-284

11-digit product format

572970284

Labeler code

57297

Product ID

57297-284_b301e8a1-05e8-4179-90de-a8c81f007b96

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

LAMIVUDINE AND ZIDOVUDINE

Dosage form

TABLET

Route

ORAL

Labeler

LUPIN LIMITED

Application

ANDA090246

Marketing category

ANDA

Marketing start

2012-05-15

Marketing end

0000-00-00

Substance

LAMIVUDINE; ZIDOVUDINE

Active strength

150 mg/1; mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]

NDC exclude flag

E

Listing certified through

2017-12-31

Current FDA listing

Historical FDA.report record